From GlobeNewswire: 2025-02-14 08:45:56

Astrotech Corporation reported Q2 revenue of $295 thousand, primarily from work with DHS on the TRACER 1000™. They also announced a research and development contract with DHS and received a purchase order for explosive trace detectors. The company’s balance sheet shows $24.7 million in cash and investments, supporting research, growth, and acquisitions. CEO Thomas B. Pickens, III highlighted the focus on marketing portable mass spectrometry instruments and new product lines for narcotics and chemical manufacturing. Astrotech is a mass spectrometry company with subsidiaries focused on different markets. Financial results for Q2 2025 show a net loss of $4.009 million.



Read more at GlobeNewswire: Astrotech Reports Second Quarter of Fiscal Year 2025